These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6443375)

  • 41. Progression time to narcotic use in a Southwestern addict population.
    Lett CR; Ingram CR
    Int J Addict; 1974; 9(2):351-4. PubMed ID: 4430528
    [No Abstract]   [Full Text] [Related]  

  • 42. Characteristics of pentazocine dependence in hospitalized patients after naloxone administration.
    Sandoval RG; Wang RI
    Psychopharmacologia; 1973 Jun; 30(3):205-15. PubMed ID: 4577443
    [No Abstract]   [Full Text] [Related]  

  • 43. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):97-101. PubMed ID: 6541694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in psychological need hierarchies between black and white drug addicts.
    Craig RJ; Olson RE
    J Clin Psychol; 1988 Jan; 44(1):82-6. PubMed ID: 3343370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of previous abuse of alcohol in a group of hospitalized drug addicts.
    Rosen A; Ottenberg DJ; Barr HL
    Proc Natl Conf Methadone Treat; 1973; 1():306-15. PubMed ID: 4808163
    [No Abstract]   [Full Text] [Related]  

  • 46. Observations on the changing face of heroin addiction in a San Francisco clinic population.
    Newmeyer JA; Gay GR
    Anesth Analg; 1974; 53(5):717-22. PubMed ID: 4472220
    [No Abstract]   [Full Text] [Related]  

  • 47. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers.
    Comer SD; Sullivan MA; Vosburg SK; Manubay J; Amass L; Cooper ZD; Saccone P; Kleber HD
    Addiction; 2010 Apr; 105(4):709-18. PubMed ID: 20403021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pentazocine abuse rises--Schedule IV status proposed.
    FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34. PubMed ID: 720788
    [No Abstract]   [Full Text] [Related]  

  • 49. Abuse of pentazocine.
    Kubicki S
    Br Med J; 1978 Sep; 2(6142):955-6. PubMed ID: 709150
    [No Abstract]   [Full Text] [Related]  

  • 50. Differences in MMPI scores of black and white compulsive heroin users.
    Penk WE; Woodward WA; Rbinowitz R; Hess JL
    J Abnorm Psychol; 1978 Oct; 87(5):505-13. PubMed ID: 701603
    [No Abstract]   [Full Text] [Related]  

  • 51. Detoxification of rehabilitated methadone-maintained patients.
    Cushman P; Dole VP
    JAMA; 1973 Nov; 226(7):747-52. PubMed ID: 4585339
    [No Abstract]   [Full Text] [Related]  

  • 52. Talwin addict nephropathy.
    Stachura I; Jayakumar S; Pardo M
    Clin Nephrol; 1983 Mar; 19(3):147-53. PubMed ID: 6839565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulants and narcotic drugs.
    King P; Coleman JH
    Pediatr Clin North Am; 1987 Apr; 34(2):349-62. PubMed ID: 3550657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with illegal drug use among older methadone clients.
    Rosen D
    Gerontologist; 2004 Aug; 44(4):543-7. PubMed ID: 15331811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug use and initiation in prison: results from a national prison survey in England and Wales.
    Boys A; Farrell M; Bebbington P; Brugha T; Coid J; Jenkins R; Lewis G; Marsden J; Meltzer H; Singleton N; Taylor C
    Addiction; 2002 Dec; 97(12):1551-60. PubMed ID: 12472639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age of drug use and the transition from school to work.
    Leveson I
    Proc Natl Conf Methadone Treat; 1973; 2():1213-8. PubMed ID: 4808270
    [No Abstract]   [Full Text] [Related]  

  • 57. Dagga: A review of fact and fancy.
    James T
    S Afr Med J; 1970 May; 44(20):575-80. PubMed ID: 5423187
    [No Abstract]   [Full Text] [Related]  

  • 58. Exploration of the telescoping effect among not-in-treatment, intensive heroin-using research volunteers.
    Stoltman JJ; Woodcock EA; Lister JJ; Greenwald MK; Lundahl LH
    Drug Alcohol Depend; 2015 Mar; 148():217-20. PubMed ID: 25630964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pentazocine addiction?
    Mungavin JM
    Lancet; 1969 Jul; 2(7610):56-7. PubMed ID: 4182817
    [No Abstract]   [Full Text] [Related]  

  • 60. Kidney disease in blacks in North America--an overview.
    Hosten AO
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):5-8. PubMed ID: 3564137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.